Medical Devices Program Update
|
|
- Allison Sanders
- 5 years ago
- Views:
Transcription
1 Medical Devices Program Update Cindy Evans Interim Senior Executive Director Therapeutic Products Directorate Health Products and Food Branch April 29, 2015
2 Classification of Medical Devices Medical Device Regulations set out a system for classifying medical devices into one of four classes. Class I Class II Class III Class IV Low Risk Moderate Risk High Risk Increasing Regulatory Oversight 2
3 Regulatory Framework Overview Class I (low risk) Class IV (high risk) Product licensing applies to Class II, III & IV Quality Management System requirements apply to Class II, III & IV Post-market requirements apply to all Classes Establishment Licensing applies primarily to importers/distributors/class I manufacturers Percentage of Devices on Market Class IV Class III Class II Class I 3
4 Delivery of the Medical Devices Program Health Products and Food Branch (HPFB) Therapeutic Products Directorate (TPD-MDB) Marketed Health Products Directorate (MHPD) Health Products and Foods Branch Inspectorate (HPFBI) Regions and Programs Bureau (RAPB) Halifax, Longueuil, Toronto, Winnipeg, Edmonton, Burnaby 4
5 Medical Devices Program Performance 5
6 Therapeutic Products Directorate Medical Devices Bureau Including data up to March 31,
7 Class II Applications Received and Licences Issued 7
8 Class III Applications Received and Licences Issued 8
9 Class IV Applications Received and Licences Issued 9
10 10
11 11
12 12
13 # Dec
14 14
15 15
16 16
17 Health Products and Food Branch Inspectorate (Includes data up to Dec 31, 2014) 17
18
19
20
21
22
23
24 Marketed Health Products Directorate
25 25
26 # Voluntary Medical Device Problem & CMDSNet Reports * Source MDS/Repository stats as of Feb 28/15 26
27 Requests for Additional Information and Screening Deficiencies 27
28 28
29 Most Common Additional Information Requests Class III and IVDD IV Devices New and Amendment Applications Safety and Effectiveness Studies Device Labels, Package Labelling and Documentation Background Information Marketing History/Regulatory Status 29
30 Most Common Screening Deficiencies Class III and IVDD IV Devices New and Amendment Applications Safety and Effectiveness Studies Background Information Fees Device Labels, Package Labelling and Documentation Manufacturing Quality Controls Licensing Also for Non-IVD Marketing History/Regulatory Status 30
31 Application Quality Report Card launched in April 2014 Objective: Provide feedback to applicants on quality of applications Help manufacturers ensure that future applications are of the best quality Improve the timeliness of MDB s review process Reduce the number of Requests for Additional Information 31
32 Quality Report Card: Initial Outcomes 100% All Sections (July to February 90% 80% 70% 60% 50% 40% 30% POOR ACCEPTABLE EXCELLENT 20% 10% 0% 32
33 Quality Report Card: Initial Observations Quality of submissions has stayed relatively consistent Most applications submitted are of acceptable quality For each category, there are approximately 10% of applications with poor quality information Overall, approximately 20% of applications received at least one rating of poor in one of the categories listed. There remains opportunity for manufacturers to improve the quality of submissions 33
34 List of Recognized Standards for Medical Devices Updated on Health Canada s website Recent update posted New update to be posted very shortly for consultation Guidance Document: Recognition and Use of Standards under the Medical Devices Regulations 34
35 Special Access Programme: Draft Guidance Document A draft guidance document for health care professionals on special access and custom-made medical devices was distributed via to active health care professionals, industry stakeholders, MEDEC, and the Canadian Medical Association for comment in late March, with a 60 day consultation period This guidance document is intended for health care professionals seeking Special Access to a medical device The guidance document: clarifies the mandate, intent and scope of the Special Access Programme outlines the responsibilities of the health care professional, manufacturers and Health Canada in the process. 35
36 Transparency - Regulatory Decision Summary Starting in April 2015, the Medical Devices Bureau will be publishing Regulatory Decision Summaries (RDS) A document summarizing positive licensing decisions for class IV medical devices in Phase I Eventually will be published for all positive licensing decisions The RDS will include basic information about what was licensed and a brief summary of information that was reviewed to come to a licensing decisions The RDS will be approximately 1 page in length 36
37 Application Formats Pre December 1, 2014 No standardized format Accepting electronic AND paper premarket review documents Post December 1, prescribed formats (STED, HC, ToC) Accepting electronic only premarket review documents Desired Future state Implement a standard, internationally harmonized, submission structure for Class III and IV medical device licence applications (IMDRF ToC) Move to fully electronic review environment 37
38 TOC Implementation Pilot Pilot Objectives: Gain experience with the ToC and develop HC guidance Provide input to IMDRF for consideration in their pilot Milestones: October 2014 invitation to participate in pilot was sent November 2014 pilot began, 26 companies September 2015 target end date for pilot As of April 7, 2015 manufacturers of 15 applications have notified of their intent to submit: 4 not yet received, 5 in screening, 5 in review queue, 1 under review 38
39 Medical Devices Single Audit Program (MDSAP) Designed and developed to provide a single efficient audit of the medical device manufacturers while ensuring coverage of all of the jurisdictions requirements (Australia, Brazil, Canada & USA) in a regulatory audit Currently seven Auditing Organizations have applied, and seven manufacturers are participating in the pilot Medical device manufacturers interested in the program should contact the Auditing Organization of their choice to determine if they are - or when they expect to be - authorized to perform MDSAP Pilot audits. HC link: FDA link: 39
40 Commercial Reprocessing of Single Use Devices In February 2015, Health Canada announced its regulatory approach to begin regulating commercial reprocessors of medical devices originally labelled for single use. Companies that reprocess and distribute medical devices originally authorized and labelled for single use to Canadian healthcare facilities will be subject to the Regulations. 40
41 Commercial Reprocessing of Single Use Devices These companies must meet the same requirements as current licence holders, including the following: Licensing Quality Management System (QMS) Conducting Recalls Mandatory reporting of incidents Inform Health Canada of any changes to the information in their licence application 41
42 Transition Period By September 1, 2016 all commercially reprocessed single use devices are expected to be in compliance with the Regulations. Health Canada is meeting with manufacturers and industry associations to promote awareness of the regulatory requirements. Health Canada has currently licensed one reprocessed single use device (compression sleeve). 42
43 Questions? 43
44 Additional Background on the Medical Devices Program and Regulatory Framework 44
45 Brief History 45
46 Quality Management System ISO 13485:2003 Quality Management Systems Certificate Recognized Registrars: BSI Group America (US) Intertek (CN) LRQA (US) SGS (UK) Dekra (Netherlands) G-MED (France) NSAI (Ireland) SAI (Australia) DQS (GER)TÜV-NORD (GER) TGA (Australia) UL (USA) TÜV SÜD (US) TUV Rhineland (US) TUV USA (US) 46
47 Special Access Programme Overview Part 2 of the Medical Devices Regulations, the Special Access Provisions, permits health care professionals to access custom-made and/or unlicensed medical devices for: Emergency Use, or Conventional Therapies have: Failed, or Are unavailable, or Are unsuitable 24/7 Service for health care professionals across Canada ~ 6000 applications received annually ~ 610 unique medical devices requested in
48 Industry Role & Regulatory Obligations: Pre-SAP approval Health Care Professional completes and submits an application The manufacturer should NOT complete any portion of the medical rationale section of the application form, including handing out pre-filled template applications to health care professionals (even if the health care professional asks for one) Health Canada may contact the manufacturer to request technical information about a medical device requested under the SAP. Please respond as soon as possible, bearing in mind that Health Canada must have sufficient time to review information prior to granting an authorization. Unlicensed devices accessed under SAP cannot be advertised or otherwise promoted (even if previously authorized at the same facility under SAP) Successful RFP contracts cannot be fulfilled under the Part 2 provisions A Special Access Authorization must be granted prior to importation OR sale (distribution) Ultimate decision to provide requested device lies with the manufacturer 48
49 Industry Role & Regulatory Obligations: Post-SAP approval Unique Authorization for Importation and/or Sale An authorization is valid for importation and/or sale not to exceed the quantity of devices specified. An authorization is not valid for successive purchases. Labelling Labelling For Special Access Use Only must be present on the SAP-approved medical device prior to importation and sale Distribution Records Distribution records must be maintained, according to sections 52 to 56 of the Regulations Adverse Events Adverse Events should be reported to MHPD using the industry reporting form Recalls Voluntary recalls of SAP-approved medical devices should be communicated directly to the Special Access Programme Licensing Authorizations through the SAP are not to be used as circumvention of licensing requirements. Requests may be refused if it appears that the manufacturer does not intend to license their device. 49
2016 MEDEC Regulatory Conference MAY 9 11, 2016 Transformation through Collaboration
Monday, May 9, 2016 1:30 pm Registration and Coffee 2:30 2:45 pm Welcome to Linda Lindsay, Chair, MEDEC Regulatory Affairs Committee Brief welcome as the official Opening Remarks will take place on Tuesday,
More information2016 MEDEC Regulatory Conference MAY 9 11, 2016 DRAFT AGENDA
2016 Regulatory Conference MAY 9 11, 2016 DRAFT AGENDA (subject to change) Monday, May 9, 2016 1:30 pm Registration and Coffee 2:30 2:45 Welcome to Conference 2:45 3:15 Certification and Compliance Requirements
More information!!!!!!!! !!!!!!!!!!!!! Submitted!by:!!Nancy!Abbey! Executive!Director! MEDEC!!Reuse!of!SingleAUse!Devices!Task!Force!!!! June!4,!2014!
BillC&17:ImprovingPatientSafetyby RegulatingReprocessedSingle&UseMedical Devices SubmissiontotheHouseofCommons StandingCommitteeonHealth Submittedby:NancyAbbey ExecutiveDirector MEDEC ReuseofSingleAUseDevicesTaskForce
More informationFINAL STATUS DOCUMENT
GHTF/SG2/N68R3: 2005 FINAL STATUS DOCUMENT Global Harmonization Task Force Title: Summary of Current Requirements for Where to Send Adverse Event Reports. Authoring Group: GHTF Study Group 2 Endorsed by:
More informationRegulatory Inspections
Regulatory Inspections An Overview of Process, Observations, and Guidance for Investigators Alison Urton, Group Administrator Clive Hansen, Audit Team Leader Outline Regulatory History Health Canada Overview
More informationInternational trend on medical device regulatory convergence
International trend on medical device regulatory convergence Mari Shirotani, Ph.D. Division Director, Office of International Programs Pharmaceuticals and Medical Devices Agency (PMDA) 1st December, 2017
More informationFundamentals in Regulatory Affairs for Medical Technologies
Fundamentals in Regulatory Affairs for Medical Technologies Developed by Industry for Industry NFQ Level 8 9 ects The Irish Medtech Skillnet is funded by member companies and the Training Networks Programme,
More informationGAO MEDICAL DEVICES. Status of FDA s Program for Inspections by Accredited Organizations. Report to Congressional Committees
GAO United States Government Accountability Office Report to Congressional Committees January 2007 MEDICAL DEVICES Status of FDA s Program for Inspections by Accredited Organizations GAO-07-157 Accountability
More informationIVD Regulatory Update February 2015
IVD Regulatory Update February 2015 Sue Spencer Head of IVD Notified Body Copyright 2015 BSI. All rights reserved. Content IVD proposals Expected timelines Impacts: Re-classification Clinical evidence
More informationUPDATE: Regulatory Framework for Medical Devices in South Africa. SAMED Annual Conference. 14 June 2018 Jerry Molokwane
UPDATE: Regulatory Framework for Medical Devices in South Africa SAMED Annual Conference 14 June 2018 Jerry Molokwane Medicines and Related Substances Act, 1965 (Act 101 of 1965) Act 72 of 2008 and Act
More informationRole and Vision of PMDA
Role and Vision of PMDA ~Promoting Global Public Health~ Taisuke Hojo Senior Executive Director Pharmaceutical and Medical Devices Agency (PMDA) 1 st Malaysia-Japan Symposium March 10 th, 2015 Today s
More informationObservers Takuya Noro MHLW X X X Hideto Yokoi PMDA Advisor X X X Adriana Gamboa INFARMED X X X
Page 1 of 7 GHTF SG2 Meeting Location: INFARMED, Av. do Brasil, 53, 1749-004, LISBOA, PORTUGAL Date: 27-29 February 2008 Attendance: Name Organization Email 27/2 28/2 29/2 Miguel Antunes (MA) INFARMED
More informationANVISA - Enhancing marketing authorization of drugs and medical devices in accordance to the international best practices
ANVISA - Enhancing marketing authorization of drugs and medical devices in accordance to the international best practices Balbiana Verazez Sampaio Oliveira AGENDA 1. Strategic Plan 2016-2019 objectives
More informationFundamentals in Regulatory Affairs for Medical Technologies
Fundamentals in Regulatory Affairs for Medical Technologies Developed by Industry for Industry NFQ Level 8 (approval pending) The IMDA Skillnet is funded by member companies and the Training Networks Programme,
More informationIntroduction of AHWP. IMDRF Stakeholder Meeting 25 March 2015
Introduction of AHWP IMDRF Stakeholder Meeting 25 March 2015 Introduction of AHWP Contents Goals Strategic Framework Organization structure of AHWP Newly elected AHWP and AHWP TC Leaders for the term 2015
More informationHelping physicians care for patients Aider les médecins à prendre soin des patients
CMA s Response to Health Canada s Consultation Questions Regulatory Framework for the Mandatory Reporting of Adverse Drug Reactions and Medical Device Incidents by Provincial and Territorial Healthcare
More informationIVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices. Med-Info. TÜV SÜD Product Service GmbH
Med-Info International expert information for the Medical Device industry IVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices The current regulatory framework
More informationAudits/Inspections Be Prepared for Anything
Audits/Inspections Be Prepared for Anything Practices, laboratories, institutions, and clinics that participate in clinical trials are subject to audits by a number of different entities. As a primary
More informationIntroduction of Saudi Arabia Medical Device Regulatory System Ali Al Dalaan Executive Director, SFDA AHWP TC Chair
Introduction of Saudi Arabia Medical Device Regulatory System Ali Al Dalaan Executive Director, SFDA AHWP TC Chair IMDRF Meeting. 20-22 March,2018. Shanghai, China Saudi Food & Drug Authority ) Drug Food
More informationIMDRF Project: List of international standards recognized by IMDRF management committee members
List of international standards recognized by IMDRF management committee members Progress Report Dr. Matthias Neumann Federal Ministry of Health Germany matthias.neumann@bmg.bund.de Sydney, 25.9.2012 Mandate:
More informationReuse of SUDs: Using Evidence to Inform Policy
Reuse of SUDs: Using Evidence to Inform Policy Implications for Health Policy Philip D. Neufeld Medical Devices Bureau Health Canada CADTH Symposium Edmonton, AB, April 28, 2008 NEW EVIDENCE TO INFORM
More informationDrug Safety and Effectiveness. Canadian Association for Population Therapeutics April 21, 2009
Drug Safety and Effectiveness Network Canadian Association for Population Therapeutics April 21, 2009 Cynthia Sunstrum Manager, DSEN Project, Strategic Policy Branch, Health Canada ebruary 2006 Outline
More informationUnderstanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing
Understanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing Background As reported in the Spring 2009 issue of acpnews, ACP and Alberta Health and Wellness developed a new policy
More informationRe-use of Single Use Devices Implications for Hospitals
Re-use of Single Use Devices Implications for Hospitals April 28, 2008 Sudha Kutty, Director, Patient Safety and Clinical Best Practice Ontario Hospital Association Agenda About OHA Current Drivers against
More informationTake a Course of Action.
Take a Course of Action. When you choose RAPS Online University, you ll be on track to expand your regulatory knowledge and advance your career. Our comprehensive learning provides an immersive experience
More informationOverview of the Regulatory Framework for the Safety of Nuclear Power Plants in Romania
National Commission for Nuclear Activities Control ROMANIA Overview of the Regulatory Framework for the Safety of Nuclear Power Plants in Romania Cantemir Ciurea Director, Nuclear Fuel Cycle Division CNCAN
More informationNotice. Update: Increased Scope of Submissions being accepted in Electronic Common Technical Document (ectd) electronic-only filing format
Notice September 30, 2011 Our file number: 11-117819-54 Update: Increased Scope of Submissions being accepted in Electronic Common Technical Document (ectd) electronic-only filing format Health Canada
More informationCMDCAS Handbook Policies and Procedures for Sector Qualification under the Canadian Medical Devices Conformity Assessment System (CMDCAS)
CMDCAS Handbook Policies and Procedures for Sector Qualification under the Canadian Medical Devices Conformity Assessment System (CMDCAS) Standards Council of Canada Quality Management Systems Accreditation
More informationLEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS
LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS Joey Gouws MCC and Cluster: Food Control, Pharmaceutical Trade and Product Regulation NATIONAL DEPARTMENT OF HEALTH
More informationApril 17, Edition of the Joint Commission International Accreditation. SUBJECT: MITA Feedback on the 5 th Standards for Hospitals
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org April 17, 2013 Paul vanostenberg, DDS, MS Vice President Accreditation and Standards
More informationSUMMARY REPORT OF THE 17 th ACCSQ MDPWG MEETING
SUMMARY REPORT OF THE 17 th ACCSQ MDPWG MEETING INTRODUCTION 1) The 17 th Meeting of the Medical Device Product Working Group (MDPWG) was held on 25-26 April 2013 in Petaling Jaya, Malaysia. The Meeting
More informationMDUFA Performance Goals and Procedures Process Improvements Pre-Submissions Submission Acceptance Criteria Interactive Review
Page 1 MDUFA Performance Goals and Procedures... 3 I. Process Improvements... 3 A. Pre-Submissions... 3 B. Submission Acceptance Criteria... 4 C. Interactive Review... 5 D. Guidance Document Development...
More informationGuide to reporting drug shortages and discontinuations GUI-0120
Guide to reporting drug shortages and discontinuations GUI-0120 March 14, 2017 Guide to reporting drug shortages and discontinuations (GUI-0120) Author: Health Products Compliance Directorate Date issued:
More informationPost Market Surveillance (PMS): National Competent Authority Report (NCAR) Exchange Programme under IMDRF
Post Market Surveillance (PMS): National Competent Authority Report (NCAR) Exchange Programme under IMDRF SAMED Conference, 2-3/12/2015 Dr Isabelle Demade What is IMDRF? Introduction - established in 2011
More informationReport on APEC-Funded Medical Device Delegation Visit Program to Australia, and Canada and the United States
Report on APEC-Funded Medical Device Delegation Visit Program to Australia, and Canada and the United States Australia, September 21 25; Canada and United States, August 9 18, 2010 Life Sciences Innovation
More informationDiscretionary Reporting of Fitness to Drive Legislation, Roles and Responsibilities
Discretionary Reporting of Fitness to Drive Legislation, Roles and Responsibilities Elizabeth Weldon, Program Advisor Ministry of Transportation, Licensing Services Branch Kara Ronald, Deputy Registrar
More informationTopic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015
Topic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015 1. What are the CAP s views on the regulatory oversight of laboratory-developed tests (LDTs)? 2. How are
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL QUESTIONS & ANSWERS: LICENSING OF MEDICAL DEVICE ESTABLISHMENTS This document is intended to provide clarity on guidelines and applications for the licensing of medical device
More informationFINAL DOCUMENT. Global Harmonization Task Force
GHTF/SG5/N5:2012 FINAL DOCUMENT Global Harmonization Task Force Title: Reportable Events During Pre-Market Clinical Investigations Authoring Group: Study Group 5 of the Global Harmonization Task Force
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL GUIDELINES FOR RECALL/ WITHDRAWAL OF MEDICINES This document has been prepared to serve as a recommendation to applicants regarding the recalls of medicines, and the Medicines
More informationPresentation to the Federal, Provincial and Territorial (FPT) Deputy Ministers of Health Meeting
Presentation to the Federal, Provincial and Territorial (FPT) Deputy Ministers of Health Meeting Gatineau, Quebec June 10, 2011 (Amended for Project Web Page) Canadian Pharmaceutical Bar Coding Project
More informationSafety Surveillance for Medical Devices
Safety Surveillance for Medical Devices May 10, 2012 James P. Keller, M.S. Vice President, Health Technology Evaluation and Safety jkeller@ecri.org (610) 825-6000, ext. 5279 Presentation Overview ECRI
More informationDesignation of Australian conformity assessment bodies for medical devices Implementation, Version 1.0, November 2016
Designation of Australian conformity assessment bodies for medical devices, Version 1.0, November 2016 To: Business Improvement and Support Section Medical Devices Branch Therapeutic Goods Administration
More informationRegulating medical education and professions
November 4, 2016 Overview Problem statement Present arrangement NITI Aayog (NITI) draft law Strategies for reform Proposed design Part I Problem Statement Ninety-Second Report on the Functioning of the
More informationSoftware Regulation and Validation
Software Regulation and Validation Keiichiro Ozawa FUJIFILM Corporation 12/07/2016 4th Joint Conference of Taiwan and Japan on Medical Products Regulation 1 Agenda 0. Introduction 1. Qualification and
More informationGuidance for Industry - Issuance of Health Professional Communications and Public Communications by Market Authorization Holders
November 1, 2005 Our file number: 05-123389-36 NOTICE Guidance for Industry - Issuance of Health Professional Communications and Public Communications by Market Authorization Holders Health Canada is pleased
More informationMedical Devices and Device-Led Combination Products; Voluntary Malfunction Summary
This document is scheduled to be published in the Federal Register on 08/17/2018 and available online at https://federalregister.gov/d/2018-17770, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND
More informationPost Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015
Post Market Surveillance Requirements SAMED Regulatory Conference 2 December 2015 Topics Surveillance & Vigilance Adverse Events Reportable Adverse Events Reporting Adverse Events Time frames Exemptions
More informationChild Care Services Regulations 2007
Western Australia Child Care Services Regulations 2007 As at 27 Feb 2008 Version 00-c0-03 Western Australia Child Care Services Regulations 2007 CONTENTS Part 1 Preliminary 1. Citation 1 Part 2 General
More informationSubstantial Equivalency in Ontario: A Canadian Example
Equivalency Standards in Education and Regulatory Practice: International Mobility Substantial Equivalency in Ontario: A Canadian Example Lise Betteridge, MSW, RSW Deputy Registrar Ontario College of Social
More informationCALENDAR OF L ARCHE CANADA S ENGAGEMENT WITH COMMUNITIES
CALENDAR OF L ARCHE CANADA S ENGAGEMENT WITH COMMUNITIES 2016-2017 What? Why? Who? When? Notes October 2016 SERVANT LEADERSHIP () Bubble of the Month () Provide feedback and input to Draft Growth Profiles
More informationNovember 7, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org November 7, 2011 Division of Dockets Management (HFA-305) Food and Drug Administration
More informationSTATEMENT. JEFFREY SHUREN, M.D., J.D. Director, Center for Devices and Radiological Health Food and Drug Administration
STATEMENT JEFFREY SHUREN, M.D., J.D. Director, Center for Devices and Radiological Health Food and Drug Administration Institute of Medicine Committee on Patient Safety and Health Information Technology
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationSafety. 3.1 The Law Affecting Health and Safety in the UK UK Health and Safety at Work Act (HASWA) Statutory Duties of the Employer
3 Legislation Related to Health and Safety 3.1 The Law Affecting Health and Safety in the UK 3.1.1 UK Health and Safety at Work Act (HASWA) 1974 The 1974 HASWA defines the statutory duties UK employers
More informationFerring Investigator-Initiated Trials (IIT) Submission Guidelines
Ferring Investigator-Initiated Trials (IIT) Submission Guidelines WHAT WE SUPPORT The mission and purpose of the Ferring Investigator-Initiated Trial Program is to provide support for investigator-initiated
More informationPharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea
Pharmacovigilance and Managed Care Pharmacy Issues for Medication Safety in Korea Hyun Taek Shin, Pharm.D. Professor, College of Pharmacy Sookmyung University & President, Korean Academy of Managed Care
More informationChild Care Program (Licensed Daycare)
Chapter 1 Section 1.02 Ministry of Education Child Care Program (Licensed Daycare) Follow-Up on VFM Section 3.02, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of Actions Recommended Actions
More informationFDA Reauthorization Act of 2017 (FDARA)
FDA Reauthorization Act of 2017 (FDARA) April 4, 2018 PRESENTED BY: Jessica Ringel Counsel FDA & Life Sciences Practice Group King & Spalding LLP (202) 626-9259 jringel@kslaw.com FDA Reauthorization Act
More informationAccreditation of Clinical Laboratories
Accreditation of Clinical Laboratories Symposium on Traceability in Laboratory Medicine 9-11 June 2002 BIPM, Sèvres, France Alan Squirrell, ILAC Executive Regina Robertson, NATA, Australia Sean Peters,
More informationGuidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
More informationNuclear Regulatory Compliance: Enhancing Safety and Security Through a Clear Regulatory Framework
Nuclear Regulatory Compliance: Enhancing Safety and Security Through a Clear Regulatory Framework Ms. Lynn Forrest, Director, Regulatory Policy Analysis Division ACE Canada Workshop November 21, 2017 Jakarta,
More informationStandards and Medical Device Regulation Roundtable. Seoul South Korea. 21 October ASTM International
Standards and Medical Device Regulation Roundtable Seoul South Korea 21 October 2014 FDA s Use of Voluntary Consensus Standards Scott Colburn, Director CDRH Standards Program Office of the Center Director,
More informationThe U.S. Food and Drug Administration s Food Safety Modernization Act: Current & Future Requirements
The U.S. Food and Drug Administration s Food Safety Modernization Act: Current & Future Requirements Beatrice Moreau Senior Regulatory Advisor Registrar Corp 144 Research Drive Hampton, Virginia USA 23666
More informationLEGEND. Challenge Fund Application Guidelines
LEGEND Challenge Fund Application Guidelines 24 th November, 2015 1 Contents 1. Introduction... 3 2. Overview of Challenge Fund... 3 2.1 Expected results... 3 2.2 Potential grantees... 4 2.3 Window structure...
More informationThe Characteristics of an Effective Nuclear Regulator
The Characteristics of an Effective Nuclear Regulator Dr. Michael Binder, President Canadian Nuclear Law Organization 2 nd Annual Nuclear Law Course The Regulates the use of nuclear energy and materials
More informationLatham & Watkins Corporate Department
Number 1133 January 27, 2011 Client Alert Latham & Watkins Corporate Department FDA Announces Actions Designed to Improve the 510(k) Premarket Clearance Process Importantly, however, the Agency s identified
More informationFair Registration Practices Report
Fair Registration Practices Report Massage Therapists (2017) The answers seen below were submitted to the OFC by the regulated professions. This Fair Registration Practices Report was produced as required
More informationContent Sheet 11-1: Overview of Norms and Accreditation
Content Sheet 11-1: Overview of Norms and Accreditation Role in quality management system Assessment is the means of determining the effectiveness of a laboratory s quality management system. Standards,
More informationEuropean IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals
European IVD Regulations and Risk Based Classification An Overview for Global Quality Professionals Anna Sadio IVD Technical Expert/Project Manager Oct 2013 Caution The new regulations are draft and subject
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationUnlicensed Medicines Policy
Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention
More informationStandards of Practice Non-Prescription Drugs A Report to the National Association of Pharmacy Regulatory Authorities
Standards of Practice Non-Prescription Drugs A Report to the National Association of Pharmacy Regulatory Authorities The following report and proposed standards by Barry E. Allen and Linda G. Suveges were
More informationNotice. Revised Draft Guidance Document: Preparation of Drug Submissions and Applications in the Common Technical Document (CTD) Format
August 8, 2011 Notice Our file number: 11-113839-2 Re: Revised Draft Guidance Document: Preparation of Drug Submissions and Applications in the Common Technical Document (CTD) Format Health Canada is pleased
More informationHealth Canada Safety Codes
Health Canada Safety Codes Narine Martel, M. Sc. Consumer and Clinical Radiation Protection Bureau Environmental Radiation Health Sciences Directorate Healthy Environments and Consumer Safety Branch February
More informationNational Waiting List Management Protocol
National Waiting List Management Protocol A standardised approach to managing scheduled care treatment for in-patient, day case and planned procedures January 2014 an ciste náisiúnta um cheannach cóireála
More informationMay 12, 2016 MEMORANDUM. Certain provisions of FSMA are already in effect, namely: Mandatory recall authority (FSMA 206).
L A W O F F I C E S 7 0 0 T H I R T E E N T H S T R E E T, N. W. S U I T E 1 2 0 0 W A S H I N G T O N, D. C. 2 0 0 0 5-5 9 2 9 ( 2 0 2 ) 7 3 7-5 6 0 0 F A C S I M I L E ( 2 0 2 ) 7 3 7-9 3 2 9 w w w.
More informationNew EU legislation on Medical Devices. Erik Hansson Deputy Head of Unit European Commission DG Health and Consumers 1
New EU legislation on Medical Devices Erik Hansson Deputy Head of Unit European Commission DG Health and Consumers 1 Drivers for change Presentation Commission proposals State of play in negotiations What
More informationStudy of Registration Practices of the
COLLEGE OF MIDWIVES OF ONTARIO, 2007 This study was prepared by the Office of the Fairness Commissioner (OFC). We encourage its citation and distribution for non-commercial purposes, provided full credit
More informationProposed amendments to the Marihuana for Medical Purposes Regulations
Proposed amendments to the Marihuana for Medical Purposes Regulations Submission in response to the Canada Gazette publication on the proposed amendments to the Marihuana for Medical Purposes Regulations
More informationA Guide for Self-Employed Registered Nurses 2017
A Guide for Self-Employed Registered Nurses 2017 Introduction In 2013, 72 Registered Nurses reported their workplace as self-employed when they registered for the 2014 licensure year. The College of Registered
More informationInternational Trend on Medical Device Regulatory Convergence
International Trend on Medical Device Regulatory Convergence 5th Joint Conference of Taiwan and Japan on Medical Products Regulation December 1, 2017 Taipei 1 Content Overview of major international harmonization
More informationInvestigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser
Investigator-Initiated Studies: When you re the Sponsor Cheri Robert & Tammy Mah-Fraser ACRC Clinical Research Conference Edmonton, AB October 15, 2014 Session Objectives Define roles of the investigator,
More informationUniversal Safety Oversight Audit Programme Continuous Monitoring Manual
Doc 9735 AN/960 Universal Safety Oversight Audit Programme Continuous Monitoring Manual Approved by the Secretary General and published under his authority Third Edition 2011 International Civil Aviation
More informationMunicipal Interests in Liquor Licensing
Municipal Interests in Liquor Licensing Re: LS15.4 Liquor Licensing Issues Task Force October 21, 2016 Tracey Cook Executive Director, ML&S 1 Timeline of Events Dec. 2013 Apr. 2014 City Council approved
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationCHEMICALS (Classification, Labelling, Packaging of substances and mixtures -CLP) Screening Meeting EU Serbia June 2013
CHEMICALS (Classification, Labelling, Packaging of substances and mixtures -CLP) Screening Meeting EU Serbia June 2013 Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances
More informationThe use of lay visitors in the approval and monitoring of education and training programmes
Education and Training Committee, 12 September 2013 The use of lay visitors in the approval and monitoring of education and training programmes Executive summary and recommendations Introduction This paper
More informationDo you know the requirements and your responsibilities for medical device vigilance reporting?
Do you know the requirements and your responsibilities for medical device vigilance ing? A detailed review on the requirements of MDSAP participating countries in comparison with the European Medical Device
More informationMISSION REPORT ON THE INTEGRATED NUCLEAR INFRASTRUCTURE REVIEW (INIR)
MISSION REPORT ON THE INTEGRATED NUCLEAR INFRASTRUCTURE REVIEW (INIR) Counterpart: Department of Energy 30 January to 8 February 2013 Johannesburg, Republic of South Africa CONTENTS 1. EXECUTIVE SUMMARY...
More informationRegistration of a new pharmacy premises
Registration of a new pharmacy premises Send your completed application to: Pharmacy premises Applications to Register Customer Service Team General Pharmaceutical Council 25 Canada Square London E14 5LQ
More informationREPORT 2016/106. Audit of management of implementing partners at the International Trade Centre FINAL OVERALL RATING: PARTIALLY SATISFACTORY
INTERNAL AUDIT DIVISION REPORT 2016/106 Audit of management of implementing partners at the International Trade Centre Overall results relating to management of implementing partners were initially assessed
More informationCANADIAN NUCLEAR SAFETY COMMISSION S RISK BASED APPROACH TO REGULATING FUEL FACILITIES IN CANADA
Canadian Nuclear Commission canadienne Safety Commission de sûreté nucléaire CANADIAN NUCLEAR SAFETY COMMISSION S RISK BASED APPROACH TO REGULATING FUEL FACILITIES IN CANADA A Technical Paper to be presented
More informationEUROPEAN PARLIAMENT Committee on the Environment, Public Health and Food Safety
EUROPEAN PARLIAMT 2009-2014 Committee on the Environment, Public Health and Food Safety 2012/0266(COD) 12.4.2013 ***I DRAFT REPORT on the proposal for a regulation of the European Parliament and of the
More informationUK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division
UK strategy for reclassification of medicines Dr Sarah Branch, Deputy Director, VRMM Division MHRA commitment to reclassification Reclassification of medicines to non-prescription when safe to do so and
More informationAlert. Recognition of Advance Practice Registered Nurses by Michigan Statute. msms.org. April 2017
Alert April 2017 Recognition of Advance Practice Registered Nurses by Michigan Statute By Patrick J. Haddad, JD, Kerr, Russell and Weber, PLC, MSMS Legal Counsel Public Act 499 of 2016, effective April
More informationMASSACHUSETTS INSTITUTE OF TECHNOLOGY. Policy for Cost Sharing and Matching Funds on Sponsored Projects Effective July 1, 1998
INTRODUCTION This policy rescinds and supersedes the MIT Guidelines for Cost Sharing and Matching Funds on Sponsored Projects dated June 25, 1997. PURPOSE AND SCOPE The Institute must ensure that cost
More informationPOCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014)
(GLENMARIE BRANCH) POCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014) Know the requirement!! Prepared by: Dr.Lily Manorammah Contents INTRODUCTION:... 3 OUR STRATEGY... 3 MANAGEMENT REQUIREMENTS...
More informationCENTRAL SERVICE (CS) TECHNICIANS PERFORM MANY IMPORTANT
by Rose Seavey, MBA, BS, RN, CNOR, CRCST, CSPDT President/CEO of Seavey Healthcare Consulting LEGAL ISSUES: Regulations That Protect the Healthcare Worker and Their Patients LEARNING OBJECTIVES 1. Identify
More informationAUDIT UNDP BOSNIA AND HERZEGOVINA GRANTS FROM THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA. Report No Issue Date: 15 January 2014
UNITED NATIONS DEVELOPMENT PROGRAMME AUDIT OF UNDP BOSNIA AND HERZEGOVINA GRANTS FROM THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA Report No. 1130 Issue Date: 15 January 2014 Table of Contents
More information